These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 4157329)

  • 1. Action of caffeine and theophyllamine on supersensitive dopamine receptors: considerable enhancement of receptor response to treatment with DOPA and dopamine receptor agonists.
    Fuxe K; Ungerstedt U
    Med Biol; 1974 Feb; 52(1):48-54. PubMed ID: 4157329
    [No Abstract]   [Full Text] [Related]  

  • 2. Action of dopamine receptor agonists in forebrain and hypothalamus: rotational behavior, ovulation, and dopamine turnover.
    Fuxe K; Agnati LF; Corrodi H; Everitt BJ; Hökfelt T; Löfström A; Ungerstedt U
    Adv Neurol; 1975; 9():223-42. PubMed ID: 1146654
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Subchronic caffeine administration sensitizes rats to the motor-activating effects of dopamine D(1) and D(2) receptor agonists.
    Cauli O; Morelli M
    Psychopharmacology (Berl); 2002 Jul; 162(3):246-54. PubMed ID: 12122482
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A synergistic neurotrophic response to l-dihydroxyphenylalanine and nerve growth factor.
    Mena MA; Davila V; Bogaluvsky J; Sulzer D
    Mol Pharmacol; 1998 Oct; 54(4):678-86. PubMed ID: 9765511
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antidepressant-like properties of the anti-Parkinson agent, piribedil, in rodents: mediation by dopamine D2 receptors.
    Brocco M; Dekeyne A; Papp M; Millan MJ
    Behav Pharmacol; 2006 Nov; 17(7):559-72. PubMed ID: 17021388
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modulation of the motor response to dopaminergic drugs in a parkinsonian model of combined dopaminergic and noradrenergic degeneration.
    Pérez V; Sosti V; Rubio A; Barbanoj M; Rodríguez-Alvarez J; Kulisevsky J
    Eur J Pharmacol; 2007 Dec; 576(1-3):83-90. PubMed ID: 17888901
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adenosine receptor blockade reverses hypophagia and enhances locomotor activity of dopamine-deficient mice.
    Kim DS; Palmiter RD
    Proc Natl Acad Sci U S A; 2003 Feb; 100(3):1346-51. PubMed ID: 12538862
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Distinguishing whether dopamine regulates liking, wanting, and/or learning about rewards.
    Robinson S; Sandstrom SM; Denenberg VH; Palmiter RD
    Behav Neurosci; 2005 Feb; 119(1):5-15. PubMed ID: 15727507
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vivo regulation of DOPA decarboxylase by dopamine receptors in rat brain.
    Cumming P; Ase A; Laliberté C; Kuwabara H; Gjedde A
    J Cereb Blood Flow Metab; 1997 Nov; 17(11):1254-60. PubMed ID: 9390657
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An antagonistic interaction between A2B adenosine and D2 dopamine receptors modulates the function of rat carotid body chemoreceptor cells.
    Conde SV; Gonzalez C; Batuca JR; Monteiro EC; Obeso A
    J Neurochem; 2008 Dec; 107(5):1369-81. PubMed ID: 18823369
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dopamine receptor agonists and antagonists.
    Kohli JD
    Proc West Pharmacol Soc; 1990; 33():21-7. PubMed ID: 1980362
    [No Abstract]   [Full Text] [Related]  

  • 12. Effects of caffeine on aggressive behavior and avoidance learning of rats with isolation syndrome.
    Petkov VV; Rousseva S
    Methods Find Exp Clin Pharmacol; 1984 Aug; 6(8):433-6. PubMed ID: 6541736
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aminophylline may stimulate respiration in rats by activation of dopaminergic receptors.
    Lundberg DB; Breese GR; Mueller RA
    J Pharmacol Exp Ther; 1981 Apr; 217(1):215-21. PubMed ID: 6782239
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased accumulation of ( 3 H) catecholamines formed from ( 3 H) dopa after treatment with caffeine and aminophylline.
    Waldeck B
    J Pharm Pharmacol; 1972 Aug; 24(8):654-5. PubMed ID: 4403749
    [No Abstract]   [Full Text] [Related]  

  • 15. Changes of D1 and D2 dopamine receptor mRNA in the brains of monkeys lesioned with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine: correction with chronic administration of L-3,4-dihydroxyphenylalanine.
    Morissette M; Goulet M; Calon F; Falardeau P; Blanchet PJ; Bédard PJ; Di Paolo T
    Mol Pharmacol; 1996 Nov; 50(5):1073-9. PubMed ID: 8913337
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endogenous neurotensin attenuates dopamine-dependent locomotion and stereotypy.
    Chartoff EH; Szczypka MS; Palmiter RD; Dorsa DM
    Brain Res; 2004 Oct; 1022(1-2):71-80. PubMed ID: 15353215
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MK-801 alters the effects of priming with L-DOPA on dopamine D1 receptor-induced changes in neuropeptide mRNA levels in the rat striatal output neurons.
    Van De Witte SV; Groenewegen HJ; Voorn P
    Synapse; 2002 Jan; 43(1):1-11. PubMed ID: 11746728
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modification of striatal acetylcholine concentration by dopamine receptor agonists and antagonists.
    Sethy VH; VAN Woert MH
    Res Commun Chem Pathol Pharmacol; 1974 May; 8(1):13-28. PubMed ID: 4847901
    [No Abstract]   [Full Text] [Related]  

  • 19. The locomotor and stereotype response to dopaminergic drugs and caffeine after intracerebroventricular kainic acid in rats.
    Kleinrok Z; Turski L; Wawrzyniak M; Cybulska R
    Pol J Pharmacol Pharm; 1981; 33(2):149-59. PubMed ID: 7198226
    [TBL] [Abstract][Full Text] [Related]  

  • 20. RDS-127 (2-di-n-propylamino-4,7-dimethoxyindane): central effects of a new dopamine receptor agonist.
    Arnerić SP; Long JP; Williams M; Goodale DB; Mott J; Lakoski JM; Gebhart GF
    J Pharmacol Exp Ther; 1983 Jan; 224(1):161-70. PubMed ID: 6401334
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.